Eli Lilly’s Zepbound FDA Approval Impacts ResMed, Sleep Apnea Treatment Landscape
FDA approves Eli Lilly’s Zepbound for sleep apnea, impacting ResMed and offering a new alternative to CPAP. This shift expands treatment options and may change the sleep apnea landscape.
Eli Lilly’s Zepbound FDA Approval Impacts ResMed, Sleep Apnea Treatment Landscape Read More »